Mode
Text Size
Log in / Sign up

Induction of labor for suspected fetal macrosomia does not significantly affect cesarean section or shoulder dystociaInduction of Labor for Fetal Macrosomia Shows No Difference in Risks

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that induction of labor for suspected fetal macrosomia does not significantly change cesarean or shoulder dystocia rates.

This systematic review and meta-analysis evaluated the impact of induction of labor versus expectant management in 4,442 women with suspected fetal macrosomia (birth weight ≥4,000 g). The analysis synthesized both randomized controlled trials and observational studies to assess primary outcomes including cesarean section rates, shoulder dystocia, and neonatal Apgar scores. Secondary outcomes included the incidence of brachial plexus palsy.

The meta-analysis found no significant difference in cesarean section rates (RR: 1.01; 95% CI: 0.83–1.23) or shoulder dystocia (RR: 0.99; 95% CI: 0.58–1.69) between induction and expectant management. Regarding brachial plexus palsy, no significant difference was observed (RR: 0.21; 95% CI: 0.01–4.28). However, the authors noted that induction may improve neonatal Apgar scores, a finding specifically driven by evidence from randomized controlled trials.

The authors noted limitations including a discrepancy between results from RCTs and observational studies, as well as the need for larger, well-designed trials to clarify these outcomes. Clinicians may use these findings to facilitate shared decision-making, as induction does not appear to significantly alter the risk of major delivery complications or neonatal injury in this population.

Researchers analyzed data from 4,442 women with suspected fetal macrosomia, which is when a baby is expected to weigh 4,000 grams or more at birth. The study looked at whether inducing labor early offered any specific advantages or risks compared to expectant management (waiting until labor begins naturally).

The results showed that inducing labor did not significantly change the rates of C-sections or shoulder dystocia, which is when a baby's shoulders become stuck during delivery. While some evidence suggested that induction might improve certain newborn scores, this finding was specifically linked to randomized controlled trials.

Because there are differences between different types of studies, the results are not definitive. Doctors suggest that since induction does not significantly change the risk of major complications like shoulder dystocia or C-sections in these cases, the best approach is for parents and doctors to make a shared decision based on individual needs.

What this means for you:
Inducing labor for large babies does not significantly change the risk of C-sections or shoulder issues.

Common questions

Does inducing labor for a large baby increase the risk of a C-section?

The study found no significant difference in C-section rates between women who had induced labor and those who were managed expectantly. With a sample size of 4,442 women with babies expected to weigh at least 4,000 grams, the data suggests that induction does not change the likelihood of needing a surgical birth.

Is it safer to induce labor if the baby is very large?

The analysis showed no significant difference in shoulder dystocia—where a baby's shoulders get stuck—between induced and expectant management. While some evidence suggests induction might improve certain newborn scores, the risk of major complications like shoulder issues remained similar in both groups.

What should I do if my doctor suggests inducing labor for a large baby?

Because induction does not significantly change the risks of C-sections or shoulder dystocia for babies over 4,000 grams, many doctors recommend shared decision-making. You should discuss your specific health needs and preferences with your healthcare provider to decide on the best plan for your pregnancy.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
Fetal macrosomia, defined as birth weight ≥4,000 g, complicates 1%–10% of pregnancies and is associated with adverse maternal and neonatal outcomes including cesarean section, shoulder dystocia, and brachial plexus injury. The optimal management of suspected macrosomia induction of labor vs. expectant management remains controversial, with no standardized international guidelines. To comprehensively evaluate maternal and neonatal outcomes among women with suspected fetal macrosomia undergoing induction of labor compared with expectant management. We systematically searched MEDLINE, CINAHL, EMBASE, and the Cochrane Central Register of Controlled Trials from inception to December 2023. Randomized controlled trials and observational studies comparing induction of labor vs. expectant management in pregnancies with suspected fetal macrosomia were included. Primary outcomes were cesarean section, shoulder dystocia, Apgar score Thirteen studies (4 RCTs, 9 observational; N = 4,442 women) were included. Induction of labor was not associated with a significant difference in cesarean section rates compared with expectant management (RR: 1.01; 95% CI: 0.83–1.23; I2 = 19%). No significant differences were observed for shoulder dystocia (RR: 0.99; 95% CI: 0.58–1.69; I2 = 23%) or brachial plexus palsy (RR 0.21; 95% CI 0.01–4.28). For Apgar score Induction of labor for suspected fetal macrosomia does not significantly increase or decrease the risk of cesarean section or shoulder dystocia compared with expectant management. However, induction may improve neonatal outcomes as measured by Apgar scores, though this finding is driven by RCT evidence. The discrepancy between RCT and observational findings underscores the need for larger, well-designed trials to inform clinical guidelines. Clinicians should engage in shared decision-making, considering patient preferences and clinical context when managing suspected fetal macrosomia.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.